Project Details
| Status | Active |
|---|---|
| Effective start/end date | 12/17/21 → 12/17/24 |
Funding
- INC Research, LLC (Prot#ARGX-113-2003)
- arGEN-X BV (Prot#ARGX-113-2003)
Prot#ARGX-113-2003: A Phase 3b, Randomized, Open-label, Parallel-Group Study to Evaluate Different Dosing Regimens of Intravenous Efgartigimod to Maximize and Maintain Clinical Benefit in Patients With Generalized Myasthenia Gravis
- Sun, Fang (PD/PI)
Project: Research project